[{"Assets_0_Q3_USD":1702470000.0,"CommonStockSharesOutstanding_0_Q3_shares":74504835.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-292668000.0,"NetIncomeLoss_1_Q3_USD":-126326000.0,"NetIncomeLoss_3_Q3_USD":-479372000.0,"StockholdersEquity_0_Q3_USD":995204000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":74177000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":73298000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]